ArticleScientific reports2024
Assessment of urine calprotectin and YKL-40 levels in urinary tract infection diagnosis in children under 2 years of age.
Article in Scientific reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Urinary antimicrobial peptides and cytokines as biomarkers for recurrent urinary tract infection in children and adolescents.Frontiers in immunology · 2026Article
- Noninvasive salivary biomarkers (PTX3, calprotectin, and IL-8) for early-onset neonatal pneumonia: case-control differences and exploratory discrimination.Frontiers in pediatrics · 2026Article
- Presence of neutrophil extracellular traps (NETs) in different types of human urinary tract infections (UTI). A pilot study.Frontiers in immunology · 2026Article
- From bladder to kidney: calprotectin as a novel marker for differentiation of urinary tract infection.World journal of urology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Urinary tract infections (UTI) are common cause of fever in children. They often manifest with non-specific symptoms. New markers assessed in non-invasively collected urine are needed for quick and reliable diagnosis. This study evaluates the usefulness of calprotectin and YKL-40 in the diagnosis of febrile UTIs among children. 67 children aged between 1 month and 2 years took part in the study. The study group (group UTI) consisted of children with the first episode of febrile UTI (n = 20). Two control groups were created: group F - febrile children with other than UTI cause of the fever (n = 36), group H - healthy children (n = 11). Concentrations of calprotectin and YKL-40 in urine samples were determined with the use of the enzyme-linked immunosorbent assay method (ELISA). In the UTI group, the average calprotectin concentration was 1273.3 ng/ml, which was significantly higher than in group F (35.4 ng/ml) and in group H (8.0 ng/ml) (p < 0.001). The YKL-40 concentration in the UTI group was 15,542.1 pg/ml, which was also significantly higher than in group F (138.1 pg/ml) and in group H (162 pg/ml) (p < 0.01). These findings suggest that urinary YKL-40 and calprotectin could be useful markers in the differential diagnosis of febrile UTI among children.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.